Hai Mi

Founding Managing Partner
Hai was a partner at Kleiner Perkins Caufield & Byers China before he co-founded Panacea Venture with his partner James Huang. Prior to joining KPCB China, Hai was a partner DT Capital responsible for investment in life science and healthcare, and a venture partner of SB China Venture Capital (SBCVC). His investment includes BGI Tech, Symap Medical, Precise Light, and NeuInvent Inc.

Hai was Senior Director of Strategic Planning and then Vice President of Corporate Communications at WuXi AppTec in Shanghai, he also served on the board of Chemspec International (NYSE: CPC) as an independent board director and the chairman of audit committee. Earlier Dr. Mi was a research scientist at Parke-Davis Pharmaceuticals and then a senior manager at Pfizer in US.

Hai obtained a Ph.D. in organic chemistry from New York University, an MBA from The University of Chicago Booth School of Business, and a B.S. in material science from Fudan University in Shanghai.